The mRNA level of STING and its downstream target molecule including IFI16, STAT6 and NLRC3 is positive associated with the overall survival of HCC patients (97), indicating the cGAS-STING signaling factors can be used as potential prognostic biomarkers and therapeutical targets for HCC treatment in humans. The gene discussed is STING1; the disease is hepatocellular carcinoma.